**Core Concept**
The question is testing the student's knowledge of broad-spectrum systemic antifungal agents, which are medications used to treat fungal infections that affect multiple body systems. These agents often work by inhibiting fungal cell wall synthesis, ergosterol biosynthesis, or DNA and RNA synthesis.

**Why the Correct Answer is Right**
The correct answer is an echinocandin, which is a class of broad-spectrum systemic antifungal agents that inhibit the synthesis of beta-1,3-D-glucan, an essential component of the fungal cell wall. This mechanism of action is distinct from other antifungal agents, such as azoles and polyenes, which target ergosterol biosynthesis or fungal cell membrane function. The echinocandins are effective against a wide range of fungal pathogens, including Candida species, Aspergillus species, and others.

**Why Each Wrong Option is Incorrect**
* **Option A:** This option is incorrect because it refers to a polyene antifungal agent, which targets ergosterol biosynthesis and is not as broad-spectrum as the correct answer.
* **Option B:** This option is incorrect because it refers to an azole antifungal agent, which targets ergosterol biosynthesis and is not as broad-spectrum as the correct answer.
* **Option D:** This option is incorrect because it refers to a polyene antifungal agent, which targets ergosterol biosynthesis and is not as broad-spectrum as the correct answer.

**Clinical Pearl / High-Yield Fact**
The echinocandins are often used in combination with other antifungal agents to treat severe fungal infections, such as invasive aspergillosis or candidemia. They are also used to prevent fungal infections in high-risk patients, such as those undergoing chemotherapy or bone marrow transplantation.

**Correct Answer:** C. Caspofungin. Caspofungin is a broad-spectrum systemic antifungal agent that inhibits the synthesis of beta-1,3-D-glucan in fungal cell walls.